Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim
McKinsey
Moodys
Medtronic
Johnson and Johnson

Last Updated: October 23, 2019

DrugPatentWatch Database Preview

Barr Labs Inc Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for BARR LABS INC, and what generic and branded alternatives to BARR LABS INC drugs are available?

BARR LABS INC has seventeen approved drugs.

There are two tentative approvals on BARR LABS INC drugs.

Summary for Barr Labs Inc
US Patents:0
Tradenames:16
Ingredients:15
NDAs:17

Drugs and US Patents for Barr Labs Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Barr Labs Inc GLIPIZIDE glipizide TABLET;ORAL 074619-001 Apr 4, 1997 DISCN No No   Start Trial   Start Trial
Barr Labs Inc MINOCYCLINE HYDROCHLORIDE minocycline hydrochloride TABLET, EXTENDED RELEASE;ORAL 065485-005 May 18, 2012 AB RX No No   Start Trial   Start Trial
Barr Labs Inc CLOZAPINE clozapine TABLET, ORALLY DISINTEGRATING;ORAL 090308-001 Nov 25, 2015 AB RX No No   Start Trial   Start Trial
Barr Labs Inc METHYLPHENIDATE HYDROCHLORIDE methylphenidate hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 079031-004 Oct 15, 2014 AB1 RX No No   Start Trial   Start Trial
Barr Labs Inc DEXTROAMP SACCHARATE,AMP ASPARTATE,DEXTROAMP SULFATE AND AMP SULFATE amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate CAPSULE, EXTENDED RELEASE;ORAL 076536-003 Feb 12, 2013 AB RX No No   Start Trial   Start Trial
Barr Labs Inc GLIPIZIDE glipizide TABLET;ORAL 074619-002 Apr 4, 1997 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Mallinckrodt
Moodys
Merck
McKesson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.